Open Access
Open access
Frontiers in Pharmacology, том 12

From Toxicity to Selectivity: Coculture of the Fluorescent Tumor and Non-Tumor Lung Cells and High-Throughput Screening of Anticancer Compounds

Тип документаJournal Article
Дата публикации2021-10-11
ИздательFrontiers Media S.A.
Название журналаFrontiers in Pharmacology
Квартиль по SCImagoQ1
Квартиль по Web of ScienceQ1
Импакт-фактор 20215.99
ISSN16639812
Pharmacology
Pharmacology (medical)
Краткое описание

For the search of anticancer compounds in modern large chemical libraries, new approaches are of great importance. Cocultivation of the cells of tumor and non-tumor etiology may reveal specific action of chemicals on cancer cells and also take into account some effects of the tumor cell’s microenvironment. The fluorescent cell cocultivation test (FCCT) has been developed for screening of substances that are selectively cytotoxic on cancerous cells. It is based on the mixed culture of lung carcinoma cells A549’_EGFP and noncancerous fibroblasts of lung VA13_Kat, expressing different fluorescent proteins. Analysis of the cells was performed with the high-resolution scanner to increase the detection rate. The combination of cocultivation of cells with scanning of fluorescence reduces the experimental protocol to three steps: cells seeding, addition of the substance, and signal detection. The FCCT analysis does not disturb the cells and is compatible with other cell-targeted assays. The suggested method has been adapted for a high-throughput format and applied for screening of 2,491 compounds. Three compounds were revealed to be reproducibly selective in the FCCT although they were invisible in cytotoxicity tests in individual lines. Six structurally diverse indole, coumarin, sulfonylthiazol, and rifampicin derivatives were found and confirmed with an independent assay (MTT) to be selectively cytotoxic to cancer cells in the studied model.

Пристатейные ссылки: 34
Цитируется в публикациях: 1
Cyanine mitochondrial dye with slightly selective cytotoxicity against A549 cancerous cells
Skvortsov D.A., Emashova S.K., Kalinina M.A., Dontsova O.A.
Q2 Archiv der Pharmazie 2021 цитирований: 1
Involvement of Bcl-2 Activation and G1 Cell Cycle Arrest in Colon Cancer Cells Induced by Titanium Dioxide Nanoparticles Synthesized by Microwave-Assisted Hybrid Approach
Ranjan S., Dasgupta N., Mishra D., Ramalingam C.
Q1 Frontiers in Bioengineering and Biotechnology 2020 цитирований: 9
Open Access
Open access
Cell Culture Based in vitro Test Systems for Anticancer Drug Screening
Kitaeva K.V., Rutland C.S., Rizvanov A.A., Solovyeva V.V.
Q1 Frontiers in Bioengineering and Biotechnology 2020 цитирований: 49
Open Access
Open access
Molecular Mechanisms of the Efficacy of Cold Atmospheric Pressure Plasma (CAP) in Cancer Treatment
Semmler M.L., Bekeschus S., Schäfer M., Bernhardt T., Fischer T., Witzke K., Seebauer C., Rebl H., Grambow E., Vollmar B., Nebe J.B., Metelmann H., Woedtke T.V., Emmert S., Boeckmann L.
Q1 Cancers 2020 цитирований: 87
Open Access
Open access
Human lung epithelial BEAS-2B cells exhibit characteristics of mesenchymal stem cells
Han X., Na T., Wu T., Yuan B.
Q1 PLoS ONE 2020 цитирований: 16
Open Access
Open access
My journey from tyrosine phosphorylation inhibitors to targeted immune therapy as strategies to combat cancer
Levitzki A., Klein S.
Q1 Proceedings of the National Academy of Sciences of the United States of America 2019 цитирований: 8
Open Access
Open access
Clinical development of targeted and immune based anti-cancer therapies
Seebacher N.A., Stacy A.E., Porter G.M., Merlot A.M.
Q1 Journal of Experimental and Clinical Cancer Research 2019 цитирований: 112
Open Access
Open access
Identification of anticancer OATP2B1 substrates by an in vitro triple-fluorescence-based cytotoxicity screen
Windt T., Tóth S., Patik I., Sessler J., Kucsma N., Szepesi Á., Zdrazil B., Özvegy-Laczka C., Szakács G.
Q1 Archives of Toxicology 2019 цитирований: 13
Open Access
Open access
Chemoresistance of Cancer Cells: Requirements of Tumor Microenvironment-mimicking In Vitro Models in Anti-Cancer Drug Development
Jo Y., Choi N., Kim K., Koo H., Choi J., Kim H.N.
Q1 Theranostics 2018 цитирований: 58
Open Access
Open access
In vitro assays and techniques utilized in anticancer drug discovery
Ediriweera M.K., Tennekoon K.H., Samarakoon S.R.
Q2 Journal of Applied Toxicology 2018 цитирований: 52
Cytotoxicity Test Based on Human Cells Labeled with Fluorescent Proteins: Fluorimetry, Photography, and Scanning for High-Throughput Assay
Kalinina M.A., Skvortsov D.A., Rubtsova M.P., Komarova E.S., Dontsova O.A.
Q2 Molecular Imaging and Biology 2018 цитирований: 7
Future cancer research priorities in the USA: a Lancet Oncology Commission
Jaffee E.M., Dang C.V., Agus D.B., Alexander B.M., Anderson K.C., Ashworth A., Barker A.D., Bastani R., Bhatia S., Bluestone J.A., Brawley O., Butte A.J., Coit D.G., Davidson N.E., Davis M., et. al.
Q1 The Lancet Oncology 2017 цитирований: 87
Open Access
Open access
Drug screening using model systems: some basics
Cagan R.
Q1 DMM Disease Models and Mechanisms 2016 цитирований: 8
Open Access
Open access
ggplot2
Wickham H.
2016 цитирований: 6789
Capturing tumor complexity in vitro: Comparative analysis of 2D and 3D tumor models for drug discovery
Stock K., Estrada M.F., Vidic S., Gjerde K., Rudisch A., Santo V.E., Barbier M., Blom S., Arundkar S.C., Selvam I., Osswald A., Stein Y., Gruenewald S., Brito C., van Weerden W., et. al.
Q1 Scientific Reports 2016 цитирований: 149
Open Access
Open access
Метрики

Поделиться

Цитировать
ГОСТ |
Цитировать
1. Skvortsov D.A. и др. From Toxicity to Selectivity: Coculture of the Fluorescent Tumor and Non-Tumor Lung Cells and High-Throughput Screening of Anticancer Compounds // Frontiers in Pharmacology. 2021. Т. 12.
RIS |
Цитировать

TY - JOUR

DO - 10.3389/fphar.2021.713103

UR - http://dx.doi.org/10.3389/fphar.2021.713103

TI - From Toxicity to Selectivity: Coculture of the Fluorescent Tumor and Non-Tumor Lung Cells and High-Throughput Screening of Anticancer Compounds

T2 - Frontiers in Pharmacology

AU - Skvortsov, D.A.

AU - Kalinina, M.A.

AU - Zhirkina, I.V.

AU - Vasilyeva, L.A.

AU - Ivanenkov, Y.A.

AU - Sergiev, P.V.

AU - Dontsova, O.A.

PY - 2021

DA - 2021/10/11

PB - Frontiers Media SA

VL - 12

SN - 1663-9812

ER -

BibTex |
Цитировать

@article{2021,

doi = {10.3389/fphar.2021.713103},

url = {https://doi.org/10.3389%2Ffphar.2021.713103},

year = 2021,

month = {oct},

publisher = {Frontiers Media {SA}},

volume = {12},

author = {D.A. Skvortsov and M.A. Kalinina and I.V. Zhirkina and L.A. Vasilyeva and Y.A. Ivanenkov and P.V. Sergiev and O.A. Dontsova},

title = {From Toxicity to Selectivity: Coculture of the Fluorescent Tumor and Non-Tumor Lung Cells and High-Throughput Screening of Anticancer Compounds}

}

MLA
Цитировать
Skvortsov, D.A. et al. “From Toxicity to Selectivity: Coculture of the Fluorescent Tumor and Non-Tumor Lung Cells and High-Throughput Screening of Anticancer Compounds.” Frontiers in Pharmacology 12 (2021): n. pag. Crossref. Web.